Congress funds school opioid prevention—with real accountability built in
H.R. 3130 — FACTS Act · Filed by Suzanne Bonamici (D-OR) · 9 cosponsors · Introduced May 1, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill creates a federal grant program to help schools and public health agencies partner on preventing synthetic opioid misuse among teenagers, with up to 25 three-year grants funding education, training, peer counseling, and recovery programs. It also establishes an interagency task force to coordinate federal responses, amends education law to require schools to address opioid prevention in their plans, and expands federal data collection on youth synthetic opioid use and access.
Why we flagged it
The bill's core mechanism is a competitive grant program to schools and health agencies for evidence-based opioid prevention, education, and recovery services. It is a straightforward public health intervention with no deregulation, liability relief, or private subsidy.
What the text implies
- Naloxone purchase authority in school-based health centers may create liability questions if schools are expected to stock and administer the drug; the bill does not address immunity or training standards for school staff administering naloxone.
- The interagency task force includes bereaved parents and nonprofit representatives, which may create political pressure to prioritize certain prevention strategies over evidence-based ones if the task force's recommendations diverge from research.
- Data collection amendments (Monitoring the Future, Youth Risk Behavior Survey) will expand federal surveillance of youth drug use and access; while necessary for public health, this increases the granularity of data held by federal agencies on minors.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill funds evidence-based prevention, treatment, and recovery services for youth facing a genuine public health crisis, with strong accountability measures (annual reporting, evaluation, best-practice sharing) and equitable geographic distribution. No private carve-outs, liability shields, or hidden subsidies are present; the mechanism is straightforward public health investment.
Who stands to gain
- nonprofit organizations specializing in substance misuse prevention
- school-based health centers
- local and state educational agencies
- public health agencies
Named in the bill
Department of Health and Human Services, Department of Education, Centers for Disease Control and Prevention, National Institute on Drug Abuse, National Institutes of Health, Surgeon General, local educational agencies, state educational agencies, Bureau of Indian Education, Interagency Task Force on Preventing Synthetic Opioid Misuse and Overdose Among Youth
Where it stands
9 cosponsors: 5 Republicans, 4 Democrats.
- May 1, 2025 — Introduced · Congress.gov: “Introduced in House”
- May 1, 2025 — Referred to House Committee on Energy and Commerce and House Committee on Education and Workforce · Congress.gov: “Referred to the Committee on Education and Workforce, and in addition to the Committee on Energy and…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 lobbying clients named this bill on 2 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $190,000 in lobbying spend. A filing names 14 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 0% of bills with at least one filing.
Suzanne Bonamici, the sponsor, reported $461,650 in PAC receipts in the 2026 cycle.
- National Association of Elementary School Principals (naesp) — $190,000 on 2 filings
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (19,822 characters) on Aug 18, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Dec 2025 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“Congress funds school opioid prevention—with real accountability built in” QuorumCivic. https://share.quorumcivic.app/bill/119/hr3130 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.